Biocon Q3FY23 revenue at Rs 3,020 crore, up 36 percent MD Bureau15 Feb 2023 11:15 AM IST"We reported a strong EBITDA growth of 35 percent to Rs 723 crore, representing a healthy EBITDA margin of 24 percent. Core EBITDA grew 49 percent to...
Syngene, Zoetis ink pact to manufacture drug substance for Librela Ruchika Sharma16 July 2022 11:33 AM ISTMumbai: Syngene International Limited has recently announced the signing of a 10-year agreement with leading animal health company, Zoetis, to...
Syngene announces expansion of biomanufacturing capacity Ruchika Sharma14 Aug 2021 11:00 AM ISTBengaluru: Syngene International, an integrated research, development and cGMP manufacturing services company, has announced the expansion of its...
Syngene appoints Alex Del Priore, Dr Alan Collis as new senior leaders in US Ruchika Sharma5 Aug 2021 11:00 AM ISTBengaluru: Syngene International has recently announced that the company has appointed two senior leaders, Alex Del Priore and Dr. Alan Collis, with...
Cipla, Mylan, others directed to allocate Remdesivir to states, UTs as per Govt supply plan Medical Dialogues Team9 May 2021 11:15 AM ISTNew Delhi: In continuation of the allocation plan of Remdesivir drug for the period 21st April to 9th May, the Ministry of Health and Family Welfare...
Syngene, HiMedia collaborate to launch COVID-19 test kits under brand name ELISafe 19 in India Farhat Nasim3 Jun 2020 1:30 PM ISTAs part of the collaboration, Syngene will initiate tech-transfer of the kits to HiMedia for developing the prototypes for submission to CDSCO for...
Syngene reports Q4 growth Ruchika Sharma13 May 2020 3:55 PM ISTBengaluru: Syngene International Limited has announced its fourth quarter and full-year FY20 results. The Company posted quarterly revenue of Rs. 628...
COVID-19 Testing Kits: Mylab joins hands with Syngene International Ruchika Sharma27 April 2020 1:16 PM ISTPune: In a major step to make India self-reliant in COVID-19 testing, Mylab Discovery Solutions, a Pune based molecular diagnostics has collaborated...
Biocon Fixes Rs 240-250/share for R&D arm Syngene's IPO Meghna A Singhania16 July 2015 5:10 PM ISTSyngene's IPO to open end of this monthBiocon, the Indian Biopharmaceutical giant is all set to roll out the IPO of its R&D arm Syngene...
